Other languages Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
8.34 ^CNY	+0.36%		-4.14%	-10.90%

16/05	Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops	MT
29/04	Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hisun Pharma's Veterinary Arm Gets Nod to Market Selamectin Drops	16/05
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Zhejiang Hisun Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	23/12
Zhejiang Hisun Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	22/12
Hisun Pharmaceutical's Unit Gets Certification for Imported Drug from Pfizer	15/12
Hisun Pharmaceutical CFO Resigns	30/11
Hisun Pharmaceutical's Unit Gets Import Drug Certificate for Methylprednisolone Tablets	29/11
Hisun Pharmaceutical's Unit Gets Nod for Carprofen Tablets for Dogs	29/11
Hisun Pharma Registers New Veterinary Drug	09/11
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27
Hisun Pharmaceutical Gets China Nod to Market Cytarabine	11/23/11
Shanghai Shyndec Pharma Gets Nod to Market Blood Sugar Drug Ingredient	14/23/14
Hisun Pharma Chairman, Vice Chairman Resign	01/23/01
Zhejiang Hisun Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	04/23/04
Hisun Pharmaceutical Gets European Certificate for Veterinary Drug Ingredient	31/23/31
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug	26/23/26
Hisun Pharma Gets Certification for Drug for Dogs	06/23/06
Hisun Pharmaceutical Unit Gets Nod to Produce Veterinary Drugs	26/23/26
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China	09/23/09

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Zhejiang Hisun Pharmaceutical Co., Ltd.

Equities

600267

CNE0000013Z2

Other languages

Filters